This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top IPOs of 2009: Five Stocks to Watch

Mead Johnson Nutrition

Mead Johnson Nutrition's (MJN - Get Report) IPO was an anomaly, Walker says. As the first deal of 2009, investors were eager to grasp on to any good news coming out of the market.

"For this reason its weight is disproportionate to the rest of the group," Walker says. "It is similar to when Visa (V - Get Report)came to market in 2008. Mead is a well-known name that already has market penetration."

A subsidiary of Bristol-Myers Squibb (BMY), Mead Johnson Nutrition makes formula for infants, most notably under the name Enfamil, as well as nutrition products for children.

On February 11, the company offered 30 million shares at $24 apiece, to raise $720 million. Bristol-Myers said it spun off Mead to help accelerate its growth.

In the third quarter, earnings slid 5% to $97.6 million, due to weak sales in North America and Europe. As a result of the Mead's IPO, it now has more stock available, and its per-share profit tumbled 21% to 48 cents from 61 cents.

Excluding one-time costs and benefits, the company said it earned 53 cents a share. Revenue fell 6% to $699.8 million from $742.8 million.

Since its IPO, Mead's stock has soared 87.5% to close at $44.99 on Jan. 4. In the fall it announced that it will begin making powder infant formula, which should be available next year.

Last month, Bristol-Myers split off its holdings in the company. The stock swap allowed Bristol-Myers shareholders to exchange some, all or none of their shares for Mead stock tax-free and at a discount. For each $1 of Bristol-Myers stock swapped, shareholders received about $1.11 worth of Mead shares.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LIWA $0.00 0.00%
CYOU $18.45 6.34%
CSCO $25.76 0.12%
GE $26.34 4.60%
HP $49.28 5.16%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs